Sera Prognostics (SERA) EBITDA Margin (2020 - 2026)
Sera Prognostics' (SERA) quarterly EBITDA Margin came in at 66857.14% in Q1 2026, down 4251504.0% YoY from N/an in Q1 2025, and up 25.33% on a QoQ basis from 89540.0% in Q4 2025.
Sera Prognostics (SERA) EBITDA Margin (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of EBITDA Margin data on file, last reported at 66857.14% in Q1 2026.
- Quarterly EBITDA Margin fell 4251504.0% year-over-year to 66857.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 64235.09% (down 3224552.0% YoY) and the FY2025 annual result came in at 45066.67%, up 251126.0% from the prior year.
- EBITDA Margin climbed to 66857.14% in Q1 2026, from 89540.0% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 9317.07% in Q2 2023 to a low of 89540.0% in Q4 2025.
- A 5-year average of 33630.64% and a median of 27450.36% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin surged 3223000 bps — and 2025, when it sank 5027750 bps.
- Tracing SERA's EBITDA Margin over 5 years: stood at 16027.69% in 2022, then plunged by 35 bps to 21580.49% in 2023, then tumbled by 82 bps to 39262.5% in 2024, then slumped by 128 bps to 89540.0% in 2025, then climbed by 25 bps to 66857.14% in 2026.
- The last three EBITDA Margin figures came in at 66857.14% (Q1 2026), 89540.0% (Q4 2025), and 56125.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | -33,346.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33,346.67% |
| Mar 31, 2026 | -66,857.14% |
| Dec 31, 2025 | -89,540.00% |
| Sep 30, 2025 | -56,125.00% |
| Jun 30, 2025 | -54,823.53% |
| Mar 31, 2025 | -24,342.11% |
| Dec 31, 2024 | -39,262.50% |
| Sep 30, 2024 | -30,558.62% |
| Jun 30, 2024 | -38,554.17% |
| Dec 31, 2023 | -21,580.49% |
| Sep 30, 2023 | -19,485.71% |
| Jun 30, 2023 | -9,317.07% |
| Mar 31, 2023 | -11,329.00% |
| Dec 31, 2022 | -16,027.69% |
| Sep 30, 2022 | -12,859.77% |
| Jun 30, 2022 | -15,058.97% |
| Mar 31, 2022 | -32,368.42% |
| Dec 31, 2021 | -48,257.69% |
| Sep 30, 2021 | -41,052.17% |
| Jun 30, 2021 | -36,905.00% |